Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
272 | 3 | TOLL LIKE RECEPTORS//INFLAMMASOME//IMMUNOLOGY | 43791 |
911 | 2 | STAT3//GP130//ONCOSTATIN M | 11400 |
12914 | 1 | TOFACITINIB//JAK3//JANUS KINASE | 903 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | TOFACITINIB | authKW | 1533736 | 9% | 54% | 82 |
2 | JAK3 | authKW | 709135 | 6% | 40% | 51 |
3 | JANUS KINASE | authKW | 621573 | 8% | 25% | 71 |
4 | BARICITINIB | authKW | 393213 | 1% | 87% | 13 |
5 | CP 690 550 | authKW | 335043 | 1% | 80% | 12 |
6 | JANUS KINASE INHIBITOR | authKW | 312789 | 2% | 41% | 22 |
7 | JAK3 INHIBITOR | authKW | 251277 | 1% | 60% | 12 |
8 | JAK1 INHIBITOR | authKW | 223362 | 1% | 80% | 8 |
9 | JANUS KINASE 3 | authKW | 218440 | 1% | 48% | 13 |
10 | TYK2 | authKW | 218103 | 2% | 31% | 20 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Rheumatology | 3991 | 12% | 0% | 111 |
2 | Immunology | 1535 | 21% | 0% | 188 |
3 | Chemistry, Medicinal | 1180 | 11% | 0% | 102 |
4 | Biochemistry & Molecular Biology | 472 | 22% | 0% | 202 |
5 | Pharmacology & Pharmacy | 386 | 14% | 0% | 129 |
6 | Cell Biology | 348 | 12% | 0% | 107 |
7 | Transplantation | 330 | 4% | 0% | 39 |
8 | Hematology | 278 | 6% | 0% | 55 |
9 | Dermatology | 88 | 3% | 0% | 26 |
10 | Chemistry, Organic | 62 | 5% | 0% | 49 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL IMMUNOL INFLAMMAT BRANCH | 218073 | 4% | 18% | 35 |
2 | TRANSLAT IMMUNOL SECT | 124083 | 1% | 44% | 8 |
3 | ANTIBACTERIALS IMMUNOL | 104703 | 0% | 100% | 3 |
4 | EXPT BMT PROGRAM | 78525 | 0% | 75% | 3 |
5 | CNRS UMR 9942 | 69802 | 0% | 100% | 2 |
6 | INFLAMMAT PULM DIS TEAM | 69802 | 0% | 100% | 2 |
7 | IRMA LERMA RANGEL ILR PHARM | 69802 | 0% | 100% | 2 |
8 | PEDIAT RHEUMATOL BRANCH | 69802 | 0% | 100% | 2 |
9 | CARDIOTHORAC SURGTRANSPLANTAT IMMUNOL | 62819 | 0% | 60% | 3 |
10 | LYMPHOCYTE CELL BIOL SECT | 49841 | 1% | 14% | 10 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT | 5945 | 1% | 2% | 7 |
2 | ARTHRITIS & RHEUMATOLOGY | 3712 | 1% | 1% | 11 |
3 | ANNALS OF THE RHEUMATIC DISEASES | 2379 | 3% | 0% | 25 |
4 | EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 1465 | 1% | 1% | 6 |
5 | ARTHRITIS RESEARCH & THERAPY | 1193 | 1% | 0% | 11 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1172 | 3% | 0% | 30 |
7 | JOURNAL OF IMMUNOLOGY | 976 | 4% | 0% | 40 |
8 | EXPERT OPINION ON THERAPEUTIC PATENTS | 964 | 1% | 0% | 8 |
9 | CURRENT OPINION IN RHEUMATOLOGY | 781 | 1% | 0% | 6 |
10 | TRANSPLANTATION REVIEWS | 661 | 0% | 1% | 2 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TOFACITINIB | 1533736 | 9% | 54% | 82 | Search TOFACITINIB | Search TOFACITINIB |
2 | JAK3 | 709135 | 6% | 40% | 51 | Search JAK3 | Search JAK3 |
3 | JANUS KINASE | 621573 | 8% | 25% | 71 | Search JANUS+KINASE | Search JANUS+KINASE |
4 | BARICITINIB | 393213 | 1% | 87% | 13 | Search BARICITINIB | Search BARICITINIB |
5 | CP 690 550 | 335043 | 1% | 80% | 12 | Search CP+690+550 | Search CP+690+550 |
6 | JANUS KINASE INHIBITOR | 312789 | 2% | 41% | 22 | Search JANUS+KINASE+INHIBITOR | Search JANUS+KINASE+INHIBITOR |
7 | JAK3 INHIBITOR | 251277 | 1% | 60% | 12 | Search JAK3+INHIBITOR | Search JAK3+INHIBITOR |
8 | JAK1 INHIBITOR | 223362 | 1% | 80% | 8 | Search JAK1+INHIBITOR | Search JAK1+INHIBITOR |
9 | JANUS KINASE 3 | 218440 | 1% | 48% | 13 | Search JANUS+KINASE+3 | Search JANUS+KINASE+3 |
10 | TYK2 | 218103 | 2% | 31% | 20 | Search TYK2 | Search TYK2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |